State health officials say providers in Alaska have received drugs from the Massachusetts pharmacy behind the deadly outbreak of fungal meningitis.
Alaska Department of Health spokesman Greg Wilkinson says Alaska providers have not received any of the implicated injectable steroid that has been linked to the deaths of at least 15 people and the illnesses of more than 200 others in other states.
But he says the U.S. Food and Drug Administration is advising health providers nationwide to contact patients who have received any injectable drugs from the New England Compounding Center, located in Massachusetts after May 21. Wilkinson says the move is precautionary.
The providers in Alaska who have received the drugs have been notified.
